Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (6): 112-116.doi: 10.6040/j.issn.1671-7554.0.2019.001

Previous Articles    

A risk prediction model of gastritis based on examination cohort

XU Yuanyou1,2, YANG Yachao3, WANG Chunxia4, MA Xiaotian1,2, XUE Fuzhong1,2, LIU Yanxun1,2, WANG Ping5   

  1. 1. Department of Biostatistics, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    2. Cheeloo Research Center for Biomedical Big Data, Shandong University, Jinan 250012, Shandong, China;
    3. Physical Examination Department, Weihai Municipal Hospital, Weihai 264200, Shandong, China;
    4. Health Management Center, Affiliated Hospital of Jining Medical University, Jining 272000, Shandong, China;
    5. Operating Room of Qilu Hospital, Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-27

PDF (PC)

86

Abstract: Objective To construct a risk prediction model based on the physical examination data. Methods A total of 33 416 non-gastritic subjects who received their first physical examination during May 2004 and Sep. 2016 in multi-centers were involved. The Cox proportional risk model was adopted to perform variable selection by stepwise method. Ten-fold cross validation was used to test the stability of the model. Results In the observation period, 842 new gastritis cases were observed. The incidence rate was 2.52% and incidence density was 18.74‰. The variables included age, helicobacter pylori infection, albumin, basophils percentage and lymphocyte count. In the receiver operating characteristic(ROC)curve, the area under the curve(AUC)was 0.691(95%CI: 0.671-0.710). The AUC after the ten-fold cross-validation was 0.673(95%CI: 0.652-0.694). Conclusion The model we constructed can effectively predict the gastritis risk.

Key words: Examination cohort, Gastritis, Risk prediction model, Cox regression, Ten-fold cross-validation

CLC Number: 

  • R573.3
[1] 房静远, 刘文忠, 李兆申,等. 中国慢性胃炎共识意见(2012年,上海)[J]. 中国医学前沿杂志(电子版), 2013,5(7): 44-55. FANG Jingyuan, LIU Wenzhong, LI Zhaoshen, et al. Consensus on chronic gastritis in China(2012, Shanghai)[J]. Chinese Journal of Frontier Medicine(Electronic Edition), 2013, 5(7): 44-55.
[2] 刘艳萍, 王明月, 牟春笋, 等. 青少年慢性胃炎危险因素分析382例[J]. 世界华人消化杂志, 2005, 13(15): 1921-1923. LIU Yanping, WANG Mingyue, MOU Chunsun, et al. Analysis of 382 cases of risk factors for chronic gastritis in adolescents [J]. World Chinese Journal of Digestology,2005,13(15): 1921-1923.
[3] Li ZW, Wu Y, Sun Y,et al.Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia[J]. World J Gastroenterol, 2010,16(14):1788-1794.
[4] 李慕然, 刘艳迪, 唐涛,等. 幽门螺杆菌和慢性胃炎胃黏膜病理变化的关系研究[J]. 天津医药, 2015, 43(1): 54-56. LI Muran, LIU Yandi, TANG Tao, et al. Study on the relationship between the pathologic change of chronic atrophic gastritis helicobacer pylori[J]. Tianjin Medicine Journal, 2015, 43(1): 54-56.
[5] Ohyauchi M. The polymorphism interleukin-8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population[J]. Gut,2005, 54(3): 330-335.
[6] Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(11): 2487-2493.
[7] Li Z, Li J. Local expressions of TGF-beta1, TGF-beta1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis[J]. Scand J Gastroenterol, 2006, 41(9):1007-1012.
[8] Inoue I, Kato J, Tamai H, et al. Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms[J]. World J Gastroenterol, 2014, 20(6): 1485-1492.
[9] Vannella, Lucy. Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal[J]. World J Gastroenterol, 2012, 18(12): 1279.
[10] 王滨, 孙天燕, 王晓宇, 等. 胆汁反流性胃炎临床研究与分析[J]. 医学研究杂志, 2010, 39(1): 96-98. WANG Bin, SUN Tianyan, WANG Xiaoyu, et al. Clinic study and analysis of bile reflux gastritis[J]. Journal of Medical Research, 2010, 39(1): 96-98.
[11] Redéen S, Petersson F, Kechagias S, et al. Natural history of chronic gastritis in a population-based cohort[J]. Scand J Gastroenterol, 2010, 45(5): 540-549.
[12] De Vries AC, Meijer GA, Looman CW, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands[J]. Gut, 2007, 56(12): 1665-1670.
[13] Inoue M, Tajima K, Matsuura A, et al. Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: a 10-year prospective cohort study in Japan[J]. Cancer Lett,2000,161(1):105-112.
[14] 侯政昆, 刘凤斌, 李培武,等. 刘凤斌教授治疗慢性萎缩性胃炎的病例系列挖掘分析和经验总结[J]. 中国中药杂志, 2015, 40(11): 2227-2234. HOU Zhengkun, LIU Fengbin, LI Peiwu, et al. Mining analysis and experience summary for chronic atrophic gastritis cases treated by Professor LIU Feng-bin[J]. China Journal of Chinese Materia Medica,2015,40(11): 2227-2234.
[15] Zhang L, Hou YH, Wu K, et al. Proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection[J]. World J Gastroenterol, 2010, 16(29): 3664-3673.
[16] Sampieri CL, Pe(~overn)a SDL, Ochoalara M, et al. Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis[J]. World J Gastroenterol, 2010,16(12):1500-1505.
[17] 刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志,2011,19(8): 701-743.
[18] 刘文忠. “幽门螺杆菌胃炎京都全球共识”解读[J]. 胃肠病学, 2015, 20(8): 449-456. LIU Wenzhong. Discussion of gastroenterology and hepatology[J]. Chinese Journal of Gastroenterology, 2015, 20(8): 449-456.
[19] 于永强, 程秀莲, 周金才,等. 慢性萎缩性胃炎患者的危险因素与临床治疗效果观察研究[J]. 世界中医药, 2015(1): 635-636. YU Yongqiang, CHENG Xiulian, ZHOU Jincai, et al. Risk factors and clinical therapeutic effects of patients with chronic atrophic gastritis[J]. World Journal of Traditional Chinese Medicine, 2015(1): 635-636.
[20] 樊乃驹. 萎缩性胃炎危险因素调查[J]. 南昌大学学报(医学版), 1989, 3: 89-91. FAN Naiju. Investigation on risk factors of atrophic gastritis[J]. Journal of Nanchang University Medical Sciences, 1989, 3: 89-91.
[21] 杨其法, 王海英, 沈红燕, 等. 杭州市余杭区居民慢性胃炎危险因素的病例-对照研究[J]. 中国慢性病预防与控制, 2006, 14(1):27-29. YANG Qifa, WANG Haiying, SHEN Hongyan, et al. A case-control study on risk factors for chronic gastritis in Yuhang district[J].Chinese Journal of Prevention and Control of Chronic Diseases, 2006, 14(1): 27-29.
[22] Sun GY, Wu JX, Wu JS, et al. Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis[J]. Chin J Cancer Res, 2012, 24(1): 23-28.
[23] Furuta T, El-Omar E M, Xiao F, et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan[J]. Gastroenterology, 2002, 123(1): 92-105.
[24] Veijola LI, Oksanen AM, Sipponen PI, et al. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection[J]. World J Gastroenterol, 2010, 16(1): 83-88.
[25] Wang P, Ji R, Yu T, et al. Classification of histological severity of Helicobacter pylori-associated gastritis by confocal laser endomicroscopy[J]. World J Gastroenterol, 2010, 16(41): 5203-5210.
[26] Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation[J]. Br Med Bull, 1998,54(1):139-150.
[27] 吴燕洁. 慢性萎缩性胃炎转归风险预测模型的临床应用[D]. 上海: 上海交通大学, 2013.
[28] 郝秀英. 慢性胃炎发病年龄初探[J]. 中国中西医结合消化杂志,1995, 3(2): 109. HAO Xiuying. Preliminary study on the age of onset of chronic gastritis[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 1995, 3(2): 109.
[29] 聂晴, 范钟麟, 张瑛. 幽门螺杆菌在慢性胃炎病理类型及年龄分布上的特点[J]. 中国高原医学与生物学杂志, 1997,18(3): 171-173. NIE Qing, FAN Zhonglin, ZHANG Ying. Characteristics of Helicobacter pylori in pathological types and age distribution of chronic gastritis[J]. Chinese Journal of Plateau Medical and Biology, 1997, 18(3): 171-173.
[30] 吕娇燕, 何睿. 嗜碱性粒细胞对Th2细胞免疫应答调节的研究进展[J]. 国际免疫学杂志, 2012, 35(2): 99-102. LÜ Jiaoyan, HE Rui. Progress in the regulation of basophils on immune response in Th2 cells[J]. International Journal of Immunology, 2012, 35(2): 99-102.
[1] MI Qi, SHI Shuang, LI Juan, LI Peilong, DU Lutao, WANG Chuanxin. Construction of circRNA-mediated ceRNA network and prognostic assessment model for bladder cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 94-102.
[2] ZHOU Miao, BIAN Weiwei, LIU Xiaojuan, KANG Fengling, XUE Fuzhong, LIU Jing. Association between basophils percentage and chronic kidney disease: a retrospective cohort study [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 85-90.
[3] LIU Xiaojuan, JIANG Zheng, KANG Fengling, ZHOU Miao, LIN Weiqiang, XUE Fuzhong. Association between neutrophil count and nonalcoholic fatty liver disease:a prospective cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 119-123.
[4] YU Yuanyuan, WANG Chunxia, SU Ping, SUN Yuanying, XUE Fuzhong, LIU Yanxun. A prediction model to estimate risks of cataract based on health management cohort [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 104-107.
[5] ZHOU Miao, XIA Tongyao, SUN Ailing, LI Ming, SHEN Zhenwei, BIAN Weiwei, JIANG Zheng, KANG Fengling, LIU Xiaojuan, XUE Fuzhong, LIU Jing. Risk prediction model of chronic kidney disease in health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 98-103.
[6] SU Ping, YANG Yachao, YANG Yang, JI Jiadong, DAYIMU Alimu, LI Min, XUE Fuzhong, LIU Yanxun. Prediction models on the onset risks of type 2 diabetes among the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 82-86.
[7] ZHANG Guang, WANG Guangyin, WU Hongyan, ZHANG Hongyu, WANG Tingting, LI Jiqing, LI Min, KANG Fengling, LIU Yanxun, XUE Fuzhong. A prediction model of hyperlipidemia risk based on the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 72-76.
[8] WANG Chunxia, XU Yibo, YANG Ning, XIA Bing, WANG Ping, XUE Fuzhong. A prediction model for coronary heart disease risks based on health management cohort [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 66-71.
[9] LI Jiqing, ZHAO Huanzong, SONG Binghong, ZHANG Lichun, LI Xiangyi, CHEN Yafei, WANG Ping, XUE Fuzhong. Risk prediction model of cardiovascular disease based on health management cohort [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 56-60.
[10] LIU Xiaojuan, DING Lijie, KANG Fengling, ZHOU Miao, XUE Fuzhong. A prediction model for bronchial asthma risk based on a health management population [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 56-61.
[11] GU Jianhua, MA Xiaotian, LI Jiqing, XUE Fuzhong, WANG Jialin. Risk prediction model of chronic obstructive pulmonary disease in health management cohort [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 62-65.
[12] LI Xiangyi, SUN Xiubin, LU Yulian, SHEN Zhenwei, CHEN Yafei, TANG Fang, XUE Fuzhong. Relationship between uterine fibroid and hyperplasia of mammary glands: a cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 53-58.
[13] SHEN Zhenwei, JI Xiaokang, WANG Qinglian, LI Jie, XUE Fuzhong, LIU Jing. Association between nonalcoholic fatty liver disease and chronic kidney disease: a retrospective cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 43-49.
[14] ZHANG Shoucai, GAO Yu, ZHENG Guixi, YANG Yongmei, LIU Yanhong, GAO Yang, WANG Chuanxin. Diagnostic value of pepsinogen in atrophic gastritis and gastric cancer evaluation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 46-52.
[15] XIAO Juan, CHEN Qicai, ZHANG Pengpeng, CHEN Lili, CHEN Xiaoxiao, WANG Shumei. Association between serum alanine transaminase with metabolic syndrome and its components based on a longitudinal health check-up study in Dongying City, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 86-91.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd